Maximum quantity allowed is 999
Please select the quantity
CAS RN: 204005-46-9 | Product Number: E1494
SU 5416
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- Semaxinib
- 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one
- 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 100MG |
¥690.00
|
2 | Contact Us | 30 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | E1494 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__5H__1__4N__2O = 238.29 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 204005-46-9 |
| Reaxys Registry Number | 9491836 |
| MDL Number | MFCD09763655 |
Specifications
| Appearance | White to Yellow to Orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Volumetric Analysis) | min. 98.0 % |
| Melting point | 224.0 to 228.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 226 °C |
GHS
Related Laws:
| RTECS# | NM3298716 |
Transport Information:
| Customs Control Conditions (Q) |
Application
SU5416: A Selective Inhibitor of VEGF Receptor Tyrosine Kinase, Flk-1/KDR
SU5416 (semaxanib) is a selective inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinase, Flk-1/KDR (fetal liver kinase 1/kinase insert domain- containing receptor), also known as VEGF receptor 2 (VEGFR2).1-4) VEGF plays a fundamental role in mediating tumor angiogenesis and tumor growth. There are reports that SU5416 suppresses tumor growth,1-4) and also results in angioproliferative pulmonary hypertension (PAH) in adult rats.4) (The product is for research purpose only.)
References
- 1) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
- 2) Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent (a review)
- 3) Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416 (a review)
- 4) The Effects of Antiangiogenic Compound SU5416 in a Rat Model of Pulmonary Arterial Hypertension (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.